Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre Phase III Study: Addition of Radiotherapy to Standard Medical Treatment for Stage IV NSCLC

NCT04530708 is registered in ClinicalTrials.gov with Swedish Lung Cancer Study Group as lead sponsor.

NCT NCT04530708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04530708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre Phase III Study: Addition of Radiotherapy to Standard Medical Treatment for Stage IV NSCLC
Lead sponsor
Swedish Lung Cancer Study Group
Phase
Not applicable
Overall status
Unknown status
Start date
February 1, 2017
Completion date
February 1, 2026
Enrollment
162 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer, quality of life, radiotherapy, stage iv non-small cell lung cancer